NEMAMETRIX, INC
Eugene, OR · Founded 2011 · CIK 0001651873 · Biotech · Private
FishCam: an automated imaging and software system that monitors zebrafish health, population metrics, and activity levels in laboratory tanks
nemametrix.com →- Grants
- $8.3M
- 18 awards
- Sector median: 1
- Raised
- $9.4M
- 6 Form D · Feb 2019
- 91 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 16
- 1 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $20,561 | |
| Private capital raised | Form D · SEC | $150,000 | |
| Private capital raised | Form D · SEC | $249,592 | |
| Federal grant | Department of Health and Human Services · Phase I · Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | $149,850 | |
| Private capital raised | Form D · SEC | $2,507,338 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | $510,448 | |
| Private capital raised | Form D · SEC | $1,550,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Testing Lifespan/HealthspanPharmacological Interventions inHumanized C. elegans Knock-In Modelsof Dementia | $350,000 | |
| Private capital raised | Form D · SEC | $5,162,950 | |
| Federal grant | Department of Health and Human Services · Phase II · Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | $475,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Humanized LMNA Animal Model for Detecting Pathogenicity in Clinical Variants | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Resubmission: Systems for Exploring Pathogenicity in Clinical Variants of a Presynaptic Protein Involved in Epilepsy | $224,703 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Resubmission: Systems for Exploring Pathogenicity in Clinical Variants of a Presynaptic Protein Involved in Epilepsy | $224,703 | |
| Federal grant | Department of Health and Human Services · Phase I · Function-based Variant Assessment of Epilepsome Genes to Increase Diagnostic Yield | $664,094 | |
| Federal grant | Department of Health and Human Services · Phase I · Function-based Variant Assessment of Epilepsome Genes to Increase Diagnostic Yield | $664,094 | |
| Federal grant | Department of Health and Human Services · Phase I · Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Administrative Supplement: Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | $124,932 | |
| Federal grant | Department of Health and Human Services · Phase I · DanFreez: Zebrafish Genetically-Optimized for Cryogenic Storage of Embryos | $464,655 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | $388,772 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | $388,772 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | $1,289,868 | |
| Federal grant | Department of Health and Human Services · Phase I · The ToxiFin Platform: Advancing High-Throughput Screening and Mechanistic Insights For Developmental Neurotoxicants Using the Zebrafish Model | $296,420 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | $1,126,155 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2331 | GlycoEra | — | — |
| 2332 | Secura Bio, Inc. | — | $50M |
| 2333 | NEMAGEN DISCOVERIES INC | — | — |
| 2334 | NEMAMETRIX, INC | — | $9.4M |
| 2335 | TERAIMMUNE, INC. | — | $3.0M |
| 2336 | Decibel Therapeutics | — | $63M |
| 2337 | 3P BIOTECHNOLOGIES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Matt BeaudetDirector · Executive Officer
- MATT BEAUDETDirector · Executive Officer
- Trisha BrockDirector
- ANN BUNNENBERGDirector
- Chris CarlsonDirector
- CHRIS CARLSONDirector
- EVANGELINE GONZALEZDirector
- Chris HopkinsDirector
- Shawn LockeryDirector · Executive Officer
- SHAWN LOCKERYDirector · Executive Officer
- RICK MILLERDirector
- KEVIN PADRICKDirector
- Amy TykesonDirector
- Janis WeeksDirector · Executive Officer
Patents
- Model Organisms Humanized For Drug Discovery And Screeningapplication
- Monogenic Or Polygenic Disease Model Organisms Humanized With Two Or More Genesapplication
- Clinical Variant Classifier Models, Machine Learning Systems And Methods Of Useapplication
- Transgenic Animal Phenotyping Platform And Uses Thereofgranted
- Homologous Recombination Reporter Construct and Uses Thereofapplication
- High-throughput Microfluidic-based Methods For Recording Defecation Motor Program (dmp) Events In Nematodesapplication
- Phenotype-based Chemical Screensapplication
- Transgenic Animal Phenotyping Platform And Uses Thereofapplication
- Methods For Identifying Compounds Affecting Human Healthapplication
- Methods For Identifying Compounds Affecting Human Healthapplication
- Methods For Identifying Compounds Affecting Human Healthapplication
- Model Organisms Humanized For Drug Discovery And Screeningapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.